Raynaud
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tadalafil for the Treatment of Raynaud's (NCT00822354) | Northwestern University | 2008-09-01 |
| A Rho-kinase Inhibitor (Fasudil) in the Treatment of Raynaud's Phenomenon (NCT00498615) | Johns Hopkins University | 2007-04-01 |
| Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity (NCT03941184) | Mayo Clinic | 1995-01-01 |
Track Raynaud automatically
Every clearance here is in the API, with alerts when new ones post.